BAK · Braskem S.A.

Current Thesis

The defining binary the multi-year Novonor (ex-Odebrecht) controlling-stake sale has RESOLVED. The judicial share sale closed in June 2026: Shine I FIP (managed by IG4 Capital) acquired ~50.11% of voting and 34.32% of total capital, and on 2026-06-04 IG4 and Petrobras finalized a co-control shareholders' agreement built on mutual consensus (effective veto for each side). A governance-overhaul EGM is set for 2026-06-08. The tape's verdict was sell-the-news: the ADR closed 2026-06-05 at $3.48, down 7.45%, grinding to fresh lows rather than re-rating. The event the prior read was waiting on came and went with no violent pop, which is what would have made it a tradable binary. What remains is a distressed, hyper-levered turnaround story JPMorgan went Overweight 2026-05-12 (PT $5.50) on a spread-cycle bottoming thesis sitting on a balance sheet carrying $8.5B net debt, 16.81x leverage, and a subsidiary (Braskem Idesa) heading into Chapter 11. This is not a momentum setup. Default stance: stay flat, watch for a base.

Bull Case

• Control overhang cleared (June 2026): the stake sale closed. Shine I FIP (IG4 Capital) took ~50.11% voting / 34.32% total; Petrobras and the FIP co-control through a consensus framework. Removes the years-long ownership uncertainty that capped the equity. The 2026-06-08 EGM formalizes an 11-seat board (≥3 independents) and five statutory committees.
• JPMorgan upgrade to Overweight, 2026-05-12, PT $5.50 ADR (R$15 local), from Neutral. Cited 3.6x 2026 EV/EBITDA vs a 5.2x five-year average, 63% upside, "118% higher EBITDA" on spread tailwinds, return to mid-cycle by 2027, and stronger post-restructuring governance (analyst Milene Carvalho).
• Q1 2026 recurring EBITDA inflected: US$192M (R$1,006M), +76% QoQ (reported 2026-05-13), driven by Brazil/South America and US/Europe spreads plus ~US$32M of REIQ tax benefit. Middle East logistics disruptions have tightened global polyolefin supply, supporting margins.
• Deep-value optionality. A ~$3.48 ADR moves large in percentage terms on any spread or narrative shift, and the new owner is a turnaround-focused PE with direct incentive to deleverage and re-rate the equity.

Bear Case

• No accelerating price leg. The ADR fell from ~$3.80 on the JPM upgrade day to $3.48, down 7.45% on 2026-06-05 lower lows, not a breakout, and no peer cluster ripping alongside it.
• Catastrophic leverage. Adjusted net debt US$8.483B, Net Debt/Recurring EBITDA 16.81x, cash US$1.1B against heavy Q1 cash burn, Q1 net loss R$9.9B. Group credit ratings sit at distressed levels (CC / CCC- negative). The equity is a thin option on a clean restructuring.
• Braskem Idesa (75%-owned Mexico JV) sliding toward Chapter 11. Missed interest on the 2029 and 2032 notes; a ~US$250M debtor-in-possession loan is in late-stage talks; 2026-06-04 Bloomberg reported Braskem "seeking restructuring with lower payments, grace periods." A punitive in-court outcome is a live tail on the parent.
• BofA Underperform. Downgraded on liquidity concerns, PT cut to R$7.50 from R$9.00 (local). Consensus sits Reduce/Hold near $3.87 — below the JPM outlier.
• The obvious event trade is already spent. The binary that defined the name resolved without a pop; what's left is grind-it-out turnaround and refinancing risk.

Setup & Price Structure

ADR ~$3.48 (2026-06-05 close, down 7.45%; after-hours $3.49). The structure is a distressed downtrend pressing the ~$3.00 shelf the prior read flagged, not a momentum base. The JPM PT $5.50, set 2026-05-12 with the stock at $3.80, implies ~58% upside from spot but price has fallen since the upgrade, so it did not mark a turn. There is no higher-low sequence and no moving-average stack to ride; the catalyst that mattered (the stake-sale close) printed as weakness. This is the cheap-multiple-with-rolled-over-tape profile the playbook sidesteps. A future entry would require a built base and a reclaim that holds above ~$4 on volume, with the spread cycle and deleveraging both confirming chased on the breakout, not accumulated into the slide. Averaging down has no thesis to defend against 16.81x leverage and an open Idesa Chapter 11 risk.

Catalyst Calendar (next 30 days)

• 2026-06-08 Extraordinary General Meeting. Votes the post-sale governance overhaul: 11-member board (≥3 independents), 30-day meeting-notice period, five statutory committees, Petrobras–FIP consensus structure. Largely procedural; clears the structural overhang but unlikely to be a price catalyst on its own.
• Braskem Idesa Chapter 11 / DIP loan ongoing, no fixed date. ~US$250M debtor-in-possession loan in late-stage negotiation; 2026-06-04 restructuring-terms headline (Bloomberg). A filing or deal could land any week this is the live binary now; watch the tape, do not pre-position.
• Petrochemical spread / consultancy spread prints rolling. Confirmation or failure of the JPM "118% EBITDA uplift" thesis; re-compression would gut the turnaround case.
• Next scheduled earnings: Q2 2026, ~August (est.) outside the 30-day window; no earnings binary inside it.

What Would Change Our Mind

A real, tradable long would need three things to line up: (1) the ADR builds a base and reclaims ~$4 on volume with a higher-low sequence strength confirming the JPM turnaround rather than the current grind to lows; (2) Braskem Idesa resolves cleanly (DIP loan plus a restructuring on terms that do not subordinate the parent's equity), removing the Chapter 11 tail; and (3) petrochem spreads keep widening through subsequent prints, validating the Q1 EBITDA inflection. The bear/value-trap case is confirmed stay flat on a weekly ADR close below $3.00, a Braskem Idesa Chapter 11 filing on punitive terms, or a spread re-compression that reverses the +76% QoQ EBITDA rebound. A clustered sell-side downgrade wave joining BofA on liquidity would seal it.

Correlation Notes

BAK is a leveraged proxy for (a) global polyethylene/polypropylene/PVC spreads versus naphtha/ethane feedstock, (b) the BRL/USD cross (Brazil-heavy cost and revenue base, ADR translation), and (c) EM-Brazil risk appetite (loose correlation with PBR/Petrobras, VALE, EWZ). It is a price-taker, not a narrative leader moves track oil/feedstock and global petchem supply (Middle East logistics disruptions currently tightening supply, per JPM). Near term, idiosyncratic drivers the Idesa restructuring and the new IG4/Petrobras control structure dominate over sector beta. No correlation to the AI/semis/quantum momentum complex; do not bucket it there. The prior pipeline mis-tag into "commodity-materials-rare-earths" is wrong Braskem produces thermoplastic resins, not rare earths.